Chee Khoon Lee

12.3k total citations · 5 hit papers
178 papers, 7.4k citations indexed

About

Chee Khoon Lee is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Chee Khoon Lee has authored 178 papers receiving a total of 7.4k indexed citations (citations by other indexed papers that have themselves been cited), including 120 papers in Oncology, 80 papers in Pulmonary and Respiratory Medicine and 56 papers in Cancer Research. Recurrent topics in Chee Khoon Lee's work include Lung Cancer Treatments and Mutations (60 papers), Colorectal Cancer Treatments and Studies (42 papers) and Cancer Genomics and Diagnostics (39 papers). Chee Khoon Lee is often cited by papers focused on Lung Cancer Treatments and Mutations (60 papers), Colorectal Cancer Treatments and Studies (42 papers) and Cancer Genomics and Diagnostics (39 papers). Chee Khoon Lee collaborates with scholars based in Australia, United States and United Kingdom. Chee Khoon Lee's co-authors include Tony Mok, Sarah J. Lord, Val Gebski, James Chih‐Hsin Yang, Yi‐Long Wu, Suresh S. Ramalingam, Helen Mann, Matthew Links, Serban Ghiorghiu and Johnathan Man and has published in prestigious journals such as New England Journal of Medicine, Nucleic Acids Research and Journal of Clinical Oncology.

In The Last Decade

Chee Khoon Lee

163 papers receiving 7.4k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Osimertinib or Platinum–Pemetrexed in EGFR T790M–Positive Lung Cancer

2016 2.4k citations Frances A. Shepherd, Chee Khoon Lee et al. profile →
Checkpoint Inhibitors in Metastatic EGFR- Mutated Non–Small Cell Lung Cancer—A Meta-Analysis

2016 582 citations Chee Khoon Lee, Sarah J. Lord et al. Journal of Thoracic Oncology profile →
Clinical and Molecular Characteristics Associated With Survival Among Patients Treated With Checkpoint Inhibitors for Advanced Non–Small Cell Lung Carcinoma

2017 405 citations Chee Khoon Lee, Sarah J. Lord et al. profile →
Impact of EGFR Inhibitor in Non–Small Cell Lung Cancer on Progression-Free and Overall Survival: A Meta-Analysis

2013 383 citations Chee Khoon Lee, Chris Brown et al. profile →
Osimertinib As First-Line Treatment of EGFR Mutation–Positive Advanced Non–Small-Cell Lung Cancer

2017 380 citations James Chih‐Hsin Yang, Chee Khoon Lee et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Chee Khoon Lee Australia	33	5.2k	4.9k	1.8k	1.6k	598	178	7.4k
Helen Mann United Kingdom	31	4.1k 0.8×	4.6k 0.9×	1.6k 0.9×	1.2k 0.8×	304 0.5×	94	6.1k
Helen X. Chen United States	37	4.1k 0.8×	2.6k 0.5×	3.9k 2.2×	2.0k 1.2×	717 1.2×	84	8.9k
Allen Lee Cohn United States	38	4.7k 0.9×	2.4k 0.5×	1.5k 0.9×	1.3k 0.8×	1.0k 1.7×	159	6.9k
Kyung-Hun Lee South Korea	35	4.1k 0.8×	2.0k 0.4×	1.6k 0.9×	1.5k 1.0×	602 1.0×	216	6.0k
Marcia S. Brose United States	44	4.5k 0.9×	2.1k 0.4×	3.6k 2.0×	1.4k 0.9×	1.2k 2.0×	187	11.5k
Rinat Yerushalmi Israel	27	4.4k 0.9×	1.8k 0.4×	2.2k 1.2×	2.3k 1.4×	694 1.2×	119	6.7k
Federica Perrone Italy	50	3.6k 0.7×	2.7k 0.6×	2.1k 1.2×	1.3k 0.8×	1.2k 2.0×	235	7.9k
Åslaug Helland Norway	40	2.7k 0.5×	2.3k 0.5×	2.7k 1.5×	1.8k 1.1×	508 0.8×	190	6.0k
Joaquı́n Mateo United Kingdom	34	3.3k 0.6×	3.2k 0.6×	2.1k 1.2×	1.8k 1.2×	370 0.6×	148	6.1k
Henri Roché France	44	6.4k 1.2×	1.8k 0.4×	2.1k 1.2×	3.3k 2.1×	725 1.2×	213	9.0k

Countries citing papers authored by Chee Khoon Lee

Since Specialization

Citations

This map shows the geographic impact of Chee Khoon Lee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chee Khoon Lee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chee Khoon Lee more than expected).

Fields of papers citing papers by Chee Khoon Lee

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chee Khoon Lee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chee Khoon Lee. The network helps show where Chee Khoon Lee may publish in the future.

Co-authorship network of co-authors of Chee Khoon Lee

This figure shows the co-authorship network connecting the top 25 collaborators of Chee Khoon Lee. A scholar is included among the top collaborators of Chee Khoon Lee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chee Khoon Lee. Chee Khoon Lee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zhu, Jiang, Chee Khoon Lee, Isamu Okamoto, et al.. (2025). LBA77 FLAURA2: Exploratory overall survival (OS) analysis in patients (pts) with poorer prognostic factors treated with osimertinib (osi) ± platinum-pemetrexed chemotherapy (CTx) as first-line (1L) treatment (tx) for EGFR-mutated (EGFRm) advanced NSCLC. Annals of Oncology. 36. S1618–S1619.

Valdiviezo, Natalia, Pasi A. Jänne, Ying Cheng, et al.. (2024). MA12.04 FLAURA2: Impact of Tumor Burden on Outcomes of 1L Osimertinib ± Chemotherapy in Patients with EGFR-mutated Advanced NSCLC. Journal of Thoracic Oncology. 19(10). S102–S102. 5 indexed citations

Woodford, Rachel, Peey‐Sei Kok, Sarah J. Lord, et al.. (2024). Validity and Efficiency of Progression-Free Survival-2 as a Surrogate End Point for Overall Survival in Advanced Cancer Randomized Trials. JCO Precision Oncology. 8(8). e2300296–e2300296. 1 indexed citations

Wang, Mengzhao, Yan Xu, Wu‐Chou Su, et al.. (2024). Sunvozertinib monotherapy in EGFR tyrosine kinase inhibitor-resistant non-small cell lung cancer with EGFR mutations. Lung Cancer. 199. 108053–108053. 4 indexed citations

Gebski, Val, Florence Joly, Jonathan A. Ledermann, et al.. (2024). Adverse events in the placebo arm of SOLO2/ENGOT-Ov21 maintenance trial of olaparib in recurrent ovarian cancer. Gynecologic Oncology. 192. 50–55.

Hur, Yang‐Im, et al.. (2023). Combination of Radiotherapy and Atezolizumab plus Bevacizumab in Patients with Advanced Hepatocellular Carcinoma: A Pilot Study. International Journal of Radiation Oncology*Biology*Physics. 117(2). e304–e305.

Planchard, David, Pasi A. Jänne, Ying Cheng, et al.. (2023). 512MO FLAURA2: Safety and CNS outcomes of first-line (1L) osimertinib (osi) ± chemotherapy (CTx) in EGFRm advanced NSCLC. Annals of Oncology. 34. S1668–S1668.

Friedländer, Michael, Val Gebski, Alain Lortholary, et al.. (2023). Discordance between GCIG CA-125 progression and RECIST progression in the CALYPSO trial of patients with platinum-sensitive recurrent ovarian cancer. British Journal of Cancer. 130(3). 425–433. 4 indexed citations

Woodford, Rachel, Sarah J. Lord, Ian C. Marschner, et al.. (2022). PD-L1 expression as a prognostic marker in patients treated with chemotherapy for metastatic non-small-cell lung cancer. Future Oncology. 18(14). 1793–1799. 8 indexed citations

10.

Woodford, Rachel, Peey‐Sei Kok, Sarah J. Lord, et al.. (2022). The validity of progression‐free survival 2 as a surrogate trial end point for overall survival. Cancer. 128(7). 1449–1457. 10 indexed citations

11.

Gebski, Val, et al.. (2022). Adverse events in the placebo arm of maintenance therapy trials in advanced ovarian cancer: A systematic review and meta-analysis. European Journal of Cancer. 170. 169–178. 3 indexed citations

12.

Cheyne, Saskia, et al.. (2022). Extrapolating evidence for molecularly targeted therapies from common to rare cancers: a scoping review of methodological guidance. BMJ Open. 12(7). e058350–e058350. 2 indexed citations

13.

Savas, Peter, Stephen J. Luen, Elizabeth F. Blackley, et al.. (2022). Alpelisib Monotherapy for PI3K-Altered, Pretreated Advanced Breast Cancer: A Phase II Study. Cancer Discovery. 12(9). 2058–2073. 38 indexed citations

14.

Khasraw, Mustafa, Michael Weller, David Lorente, et al.. (2021). Bintrafusp alfa (M7824), a bifunctional fusion protein targeting TGF-β and PD-L1: results from a phase I expansion cohort in patients with recurrent glioblastoma. Neuro-Oncology Advances. 3(1). vdab058–vdab058. 18 indexed citations

15.

Friedländer, Michael, Sarah J. Lord, Rebecca Asher, et al.. (2021). Prognostic nomogram for progression-free survival in patients with BRCA mutations and platinum-sensitive recurrent ovarian cancer on maintenance olaparib therapy following response to chemotherapy. European Journal of Cancer. 154. 190–200. 9 indexed citations

16.

Cavalcante, Raymond G., Chee Khoon Lee, Tingting Qin, et al.. (2020). Poly-Enrich: count-based methods for gene set enrichment testing with genomic regions. NAR Genomics and Bioinformatics. 2(1). lqaa006–lqaa006. 12 indexed citations

17.

Kwok, John B., Rebecca Asher, Chee Khoon Lee, et al.. (2017). Clinical and genetic predictors of paclitaxel neurotoxicity based on patient- versus clinician-reported incidence and severity of neurotoxicity in the ICON7 trial. Annals of Oncology. 28(11). 2733–2740. 56 indexed citations

18.

Fox, Peter, Harold Hudson, Chris Brown, et al.. (2013). Markers of systemic inflammation predict survival in patients with advanced renal cell cancer. British Journal of Cancer. 109(1). 147–153. 134 indexed citations

19.

Lee, Chee Khoon, Ian C. Marschner, R. J. Simes, et al.. (2012). Increase in Cholesterol Predicts Survival Advantage in Renal Cell Carcinoma Patients Treated with Temsirolimus. Clinical Cancer Research. 18(11). 3188–3196. 53 indexed citations

20.

Roetker, Nicholas S., James A. Yonker, Chee Khoon Lee, et al.. (2012). Multigene interactions and the prediction of depression in the Wisconsin Longitudinal Study. BMJ Open. 2(4). e000944–e000944. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact